The Patent Finder

Biocrine AB

Also on record
Records under this name other than the patents Biocrine AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.

Back to Biocrine AB

PatentTitleStatus Expires Confidence
US 7,381,523Methods for identifying compounds for treating diabetes mellitus
Term ended
Term ended May 6, 2025 · From the USPTO record
Term endedTerm ended May 6, 2025From the USPTO record
US 8,507,444ApoIII and the Treatment and Diagnosis of Diabetes
Term ended
Term ended Feb 5, 2025 · High confidence
Term endedTerm ended Feb 5, 2025High confidence
US 8,030,288Methods for Identifying Compounds for the Treatment of Type 1 Diabetes
Term ended
Term ended Jan 15, 2025 · High confidence
Term endedTerm ended Jan 15, 2025High confidence
US 8,021,853Inhibition of the β3 subunit of L-type Ca2+ channels
Term ended
Term ended Jun 21, 2024 · From the USPTO record
Term endedTerm ended Jun 21, 2024From the USPTO record
US 8,084,439Methods for identifying compounds for the treatment of type 1 diabetes
Term ended
Ended no later than Apr 29, 2024 · From the USPTO record
Term endedEnded no later than Apr 29, 2024From the USPTO record
US 9,169,484Apoiii and the Treatment and Diagnosis of Diabetes
Formerly held
Term ended
Term ended Apr 29, 2024 · High confidence
Term endedTerm ended Apr 29, 2024High confidence
US 10,060,935ApoIII and the Treatment and Diagnosis of Diabetes
Term ended
Term ended Apr 29, 2024 · High confidence
Term endedTerm ended Apr 29, 2024High confidence
US 7,855,049Inositol pyrophosphates determine exocytotic capacity
Lapsed on the fee record
Ended Dec 21, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 21, 2022From the USPTO record
US 9,968,675Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
Lapsed on the fee record
Ended May 15, 2022 · From the USPTO record
Lapsed on the fee recordEnded May 15, 2022From the USPTO record
US 8,716,241ApoIII and the Treatment and Diagnosis of Diabetes
Lapsed on the fee record
Ended May 6, 2022 · High confidence
Lapsed on the fee recordEnded May 6, 2022High confidence
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited